JUSTIN LIEGMANN: Open Payments
NPI 1750513099 · GRAND BLANC, MI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,397 in 50 payments from 11 companies in 2025. Trend: 2023 $375 · 2024 $1,246 · 2025 $1,397
Food & beverage: $1,206Education: $191
| Company | Payments | Amount |
|---|---|---|
| Axsome Therapeutics, Inc. | 8 | $342 |
| Teva Pharmaceuticals USA, Inc. | 12 | $330 |
| E.R. Squibb & Sons, L.L.C. | 11 | $187 |
| Alkermes, Inc. | 5 | $135 |
| JAZZ PHARMACEUTICALS INC. | 1 | $125 |
| Otsuka America Pharmaceutical, Inc. | 3 | $84 |
| Janssen Pharmaceuticals, Inc | 4 | $83 |
| Lundbeck LLC | 2 | $32 |
| Neurocrine BioSciences, Inc. | 2 | $32 |
| Vanda Pharmaceuticals Inc. | 1 | $31 |
Products named: Auvelity, COBENFY, ARISTADA, XYWAV, REXULTI, UZEDY, SPRAVATO, AUSTEDO XR.
Industry payments across MI — which companies pay providers there.
